FILGRASTIM-AAFI: 439 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
439
Total FAERS Reports
80 (18.2%)
Deaths Reported
117
Hospitalizations
439
As Primary/Secondary Suspect
3
Life-Threatening
1
Disabilities
Prescription
Status
FDA Application: 761080 ·
First Report: 201611 · Latest Report: 20250812
What Are the Most Common FILGRASTIM-AAFI Side Effects?
#1 Most Reported
Off label use
63 reports (14.4%)
#2 Most Reported
Death
63 reports (14.4%)
#3 Most Reported
White blood cell count decreased
28 reports (6.4%)
All FILGRASTIM-AAFI Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 63 | 14.4% | 62 | 3 |
| Off label use | 63 | 14.4% | 9 | 4 |
| White blood cell count decreased | 28 | 6.4% | 0 | 8 |
| Hospitalisation | 17 | 3.9% | 1 | 16 |
| Bone pain | 15 | 3.4% | 0 | 1 |
| Malaise | 15 | 3.4% | 1 | 4 |
| Needle issue | 15 | 3.4% | 0 | 0 |
| Pyrexia | 15 | 3.4% | 1 | 12 |
| Pain | 14 | 3.2% | 0 | 2 |
| Device leakage | 11 | 2.5% | 0 | 0 |
| Drug dose omission by device | 11 | 2.5% | 0 | 0 |
| Illness | 11 | 2.5% | 1 | 1 |
| Neoplasm malignant | 11 | 2.5% | 5 | 3 |
| Drug ineffective | 10 | 2.3% | 1 | 1 |
| Diarrhoea | 9 | 2.1% | 2 | 5 |
| Therapy interrupted | 9 | 2.1% | 0 | 8 |
| Device defective | 8 | 1.8% | 0 | 0 |
| Device mechanical issue | 8 | 1.8% | 0 | 0 |
| Asthenia | 7 | 1.6% | 0 | 1 |
| Drug hypersensitivity | 7 | 1.6% | 0 | 3 |
Who Reports FILGRASTIM-AAFI Side Effects? Age & Gender Data
Gender: 60.0% female, 40.0% male. Average age: 54.8 years. Most reports from: US. View detailed demographics →
Is FILGRASTIM-AAFI Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2016 | 1 | 0 | 1 |
| 2018 | 2 | 1 | 1 |
| 2019 | 15 | 2 | 6 |
| 2020 | 16 | 6 | 7 |
| 2021 | 19 | 10 | 6 |
| 2022 | 29 | 9 | 9 |
| 2023 | 18 | 8 | 2 |
| 2024 | 18 | 1 | 5 |
| 2025 | 13 | 4 | 5 |
What Is FILGRASTIM-AAFI Used For?
| Indication | Reports |
|---|---|
| Neutropenia | 53 |
| Agranulocytosis | 19 |
| White blood cell count decreased | 16 |
| Breast cancer | 11 |
| Plasma cell myeloma | 11 |
| Breast cancer female | 9 |
| Product used for unknown indication | 7 |
| Chemotherapy | 6 |
| Colon cancer | 6 |
| Neoplasm malignant | 6 |
FILGRASTIM-AAFI vs Alternatives: Which Is Safer?
FILGRASTIM-AAFI vs FILGRASTIM-SNDZ
FILGRASTIM-AAFI vs FINASTERIDE
FILGRASTIM-AAFI vs FINASTERIDE\TAMSULOSIN
FILGRASTIM-AAFI vs FINERENONE
FILGRASTIM-AAFI vs FINGOLIMOD
FILGRASTIM-AAFI vs FINGOLIMOD LAURYL
FILGRASTIM-AAFI vs FISH OIL
FILGRASTIM-AAFI vs FISH OIL\MEDIUM-CHAIN TRIGLYCERIDES\OLIVE OIL\SOYBEAN OIL
FILGRASTIM-AAFI vs FLAGYL
FILGRASTIM-AAFI vs FLECAINIDE
Official FDA Label for FILGRASTIM-AAFI
Official prescribing information from the FDA-approved drug label.